Journal DOI 10.68956/dyh5-kwte

Creative Commons source reading · Multiple sclerosis and neuroimmunology

A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.

Karol Estrada; Christopher W Whelan; Fengmei Zhao; Paola Bronson; Robert E Handsaker; Chao Sun; John P Carulli; Tim Harris; Richard M Ransohoff; Steven A McCarroll; Aaron G Day-Williams; Benjamin M Greenberg; Daniel G MacArthur

Originally published in Nature communications · 2018-05-16

From the article

Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.

Abstract

Neuromyelitis optica (NMO) is a rare autoimmune disease that affects the optic nerve and spinal cord. Most NMO patients ( > 70%) are seropositive for circulating autoantibodies against aquaporin 4 (NMO-IgG+). Here, we meta-analyze whole-genome sequences from 86 NMO cases and 460 controls with genome-wide SNP array from 129 NMO cases and 784 controls to test for association with SNPs and copy number variation (total N = 215 NMO cases, 1244 controls). We identify two independent signals in the major histocompatibility complex (MHC) region associated with NMO-IgG+, one of which may be explained by structural variation in the complement component 4 genes. Mendelian Randomization analysis reveals a significant causal effect of known systemic lupus erythematosus (SLE), but not multiple sclerosis (MS), risk variants in NMO-IgG+. Our results suggest that genetic variants in the MHC region contribute to the etiology of NMO-IgG+ and that NMO-IgG+ is genetically more similar to SLE than MS.

Discussion

Persistence of cellular debris along with impaired killing of compromised cells are proposed to stimulate chronic inflammation in interferon-producing myeloid dendritic cells, which drive B-cell autoimmunity in SLE patients with complement component deficiency15. SLE-associated autoantibodies target damaged cell components, such as dsDNA and ribonucleoproteins. AQP4, the target of the NMO autoantibodies, was increased twofold in an animal model of muscle after exercise16.

Editorial reading guide

  • Which patient population and reference standard did the authors use?
  • Was the finding validated in a separate cohort, and how might patient selection affect it?